Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:45 PM View:  | Porter James Richard President and CEO Director | Nuvalent, Inc. (NUVL) | 15-Nov-24 | Planned Option Sale | 27,000 | $87.94 | $2,374,480.00 | (13%) 215.11K to 188.11K | |
| 19-Nov-24 4:45 PM View: | Porter James Richard President and CEO Director | Nuvalent, Inc. (NUVL) | 15-Nov-24 | Option Exercise | 27,000 | $27.85 | $751,950.00 | 14% 188.11K to 215.11K | |
| 25-Sep-24 4:44 PM View: | Shair Matthew Director | Nuvalent, Inc. (NUVL) | 23-Sep-24 | Private Sale (Planned) | 2,000 | $102.75 | $205,500.00 | (< 1%) 1.66M to 1.65M | |
| 18-Sep-24 4:50 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 16-Sep-24 | Option Exercise | 8,000 | $18.93 | $151,440.00 | 24% 33.3K to 41.3K | |
| 18-Sep-24 4:50 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 16-Sep-24 | Planned Option Sale | 8,000 | $96.47 | $771,798.00 | (19%) 41.3K to 33.3K | |
| 18-Sep-24 4:53 PM View: | Pelish Henry E. Chief Scientific Officer | Nuvalent, Inc. (NUVL) | 16-Sep-24 | Private Sale (Planned) | 32,795 | $98.92 | $3,244,140.00 | (50%) 66.09K to 33.3K | |
| 11-Sep-24 4:55 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 09-Sep-24 | Option Exercise | 3,000 | $6.89 | $20,670.00 | 9% 33.3K to 36.3K | |
| 11-Sep-24 4:55 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 09-Sep-24 | Planned Option Sale | 3,000 | $88.18 | $264,546.00 | (8%) 36.3K to 33.3K | |
| 04-Sep-24 7:52 PM View: | Noci Darlene Chief Development Officer | Nuvalent, Inc. (NUVL) | 03-Sep-24 | Planned Option Sale | 5,000 | $84.43 | $422,146.00 | (13%) 38.3K to 33.3K | |
| 04-Sep-24 7:52 PM View: | Noci Darlene Chief Development Officer | Nuvalent, Inc. (NUVL) | 03-Sep-24 | Option Exercise | 5,000 | $18.93 | $94,650.00 | 15% 33.3K to 38.3K | |
| 04-Sep-24 4:52 PM View: | Balcom Alexandra Chief Financial Officer | Nuvalent, Inc. (NUVL) | 30-Aug-24 | Planned Option Sale | 10,000 | $84.23 | $842,349.00 | (23%) 43.3K to 33.3K | |
| 04-Sep-24 4:52 PM View: | Balcom Alexandra Chief Financial Officer | Nuvalent, Inc. (NUVL) | 30-Aug-24 | Option Exercise | 10,000 | $27.85 | $278,500.00 | 30% 33.3K to 43.3K | |
| 27-Aug-24 4:51 PM View: | Shair Matthew Director | Nuvalent, Inc. (NUVL) | 26-Aug-24 | Private Sale (Planned) | 2,000 | $84.46 | $168,914.00 | (< 1%) 1.66M to 1.66M | |
| 27-Aug-24 4:44 PM View: | Conley Emily Director | Nuvalent, Inc. (NUVL) | 23-Aug-24 | Planned Private Option Sale | 3,334 | $85.02 | $283,457.00 | (57%) 5.84K to 2.51K | |
| 27-Aug-24 4:49 PM View: | Pelish Henry E. Chief Scientific Officer | Nuvalent, Inc. (NUVL) | 23-Aug-24 | Private Sale (Planned) | 10,500 | $85.08 | $893,340.00 | (14%) 76.59K to 66.09K | |
| 27-Aug-24 4:47 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 23-Aug-24 | Option Exercise | 11,000 | $23.80 | $261,750.00 | 33% 33.3K to 44.3K | |
| 27-Aug-24 4:47 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 23-Aug-24 | Planned Option Sale | 11,000 | $85.04 | $935,440.00 | (25%) 44.3K to 33.3K | |
| 27-Aug-24 4:44 PM View: | Conley Emily Director | Nuvalent, Inc. (NUVL) | 23-Aug-24 | Option Exercise | 3,334 | $13.79 | $45,975.90 | 133% 2.51K to 5.84K | (3%) |
| 09-Aug-24 4:48 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 08-Aug-24 | Planned Option Sale | 3,000 | $68.78 | $206,348.00 | (8%) 36.3K to 33.3K | |
| 09-Aug-24 4:48 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 08-Aug-24 | Option Exercise | 3,000 | $6.89 | $20,670.00 | 9% 33.3K to 36.3K | |
| 02-Aug-24 4:45 PM View: | Noci Darlene Chief Development Officer | Nuvalent, Inc. (NUVL) | 01-Aug-24 | Planned Option Sale | 5,000 | $77.22 | $386,125.00 | (13%) 38.3K to 33.3K | |
| 02-Aug-24 4:45 PM View: | Noci Darlene Chief Development Officer | Nuvalent, Inc. (NUVL) | 01-Aug-24 | Option Exercise | 5,000 | $18.93 | $94,650.00 | 15% 33.3K to 38.3K | |
| 02-Aug-24 4:43 PM View: | Balcom Alexandra Chief Financial Officer | Nuvalent, Inc. (NUVL) | 31-Jul-24 | Option Exercise | 10,000 | $27.85 | $278,500.00 | 30% 33.3K to 43.3K | |
| 02-Aug-24 4:43 PM View: | Balcom Alexandra Chief Financial Officer | Nuvalent, Inc. (NUVL) | 31-Jul-24 | Planned Option Sale | 10,000 | $79.51 | $795,074.00 | (23%) 43.3K to 33.3K | |
| 31-Jul-24 4:46 PM View: | Shair Matthew Director | Nuvalent, Inc. (NUVL) | 29-Jul-24 | Private Sale (Planned) | 2,000 | $79.59 | $159,176.00 | (< 1%) 1.66M to 1.66M | |
| 16-Jul-24 4:47 PM View: | Conley Emily Director | Nuvalent, Inc. (NUVL) | 15-Jul-24 | Planned Private Option Sale | 5,000 | $80.72 | $403,621.00 | (67%) 7.51K to 2.51K | |
| 16-Jul-24 4:47 PM View: | Conley Emily Director | Nuvalent, Inc. (NUVL) | 15-Jul-24 | Option Exercise | 5,000 | $13.79 | $68,950.00 | 199% 2.51K to 7.51K | (3%) |
| 16-Jul-24 4:45 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 12-Jul-24 | Option Exercise | 6,000 | $27.85 | $167,100.00 | 18% 33.3K to 39.3K | |
| 16-Jul-24 4:45 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 12-Jul-24 | Planned Option Sale | 6,000 | $80.16 | $480,960.00 | (15%) 39.3K to 33.3K | |
| 11-Jul-24 4:50 PM View: | Pelish Henry E. Chief Scientific Officer | Nuvalent, Inc. (NUVL) | 09-Jul-24 | Grant | 13,100 | -- | -- | 21% 63.49K to 76.59K | |
| 10-Jul-24 4:45 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 08-Jul-24 | Option Exercise | 3,000 | $6.89 | $20,670.00 | 9% 33.3K to 36.3K | |
| 10-Jul-24 4:45 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 08-Jul-24 | Planned Option Sale | 3,000 | $73.23 | $219,687.00 | (8%) 36.3K to 33.3K | |
| 26-Jun-24 4:54 PM View: | Shair Matthew Director | Nuvalent, Inc. (NUVL) | 24-Jun-24 | Private Sale (Planned) | 2,000 | $80.22 | $160,438.00 | (< 1%) 1.66M to 1.66M | |
| 14-Jun-24 4:12 PM View: | Protopapas Anna Director | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | 100% 0 to 2.5K | |
| 14-Jun-24 5:05 PM View: | Flynn James E Director 10% Owner | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 4,998 | -- | -- | < 1% 19.99M to 20.0M | |
| 14-Jun-24 4:09 PM View: | Gilliland Dwight Gary Director | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | 100% 0 to 2.5K | |
| 14-Jun-24 4:53 PM View: | Hack Andrew A. F. Director | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | < 1% 2.7M to 2.7M | |
| 14-Jun-24 4:10 PM View: | Meyers Michael L. Director | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | 100% 0 to 2.5K | |
| 14-Jun-24 4:14 PM View: | Shair Matthew Director | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | < 1% 1.66M to 1.66M | |
| 14-Jun-24 4:15 PM View: | Srivastava Sapna Director | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | 100% 0 to 2.5K | |
| 14-Jun-24 4:19 PM View: | Wheeler Cameron Director | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | 100% 0 to 2.5K | |
| 14-Jun-24 4:17 PM View: | Pearlberg Joseph Director | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | 100% 0 to 2.5K | |
| 14-Jun-24 4:07 PM View: | Conley Emily Director | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 2,499 | -- | -- | 31238% 8 to 2.51K | |
| 07-Jun-24 4:44 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 06-Jun-24 | Planned Private Option Sale | 8,000 | $80.40 | $643,213.00 | (19%) 41.3K to 33.3K | |
| 07-Jun-24 4:44 PM View: | Miller Deborah Ann Chief Legal Officer | Nuvalent, Inc. (NUVL) | 06-Jun-24 | Option Exercise | 8,000 | $14.41 | $115,320.00 | 24% 33.3K to 41.3K | (7%) |
| 29-May-24 4:43 PM View: | Shair Matthew Director | Nuvalent, Inc. (NUVL) | 28-May-24 | Private Sale (Planned) | 2,000 | $67.22 | $134,438.00 | (< 1%) 1.66M to 1.66M | |
| 17-May-24 4:41 PM View: | Conley Emily Director | Nuvalent, Inc. (NUVL) | 15-May-24 | Planned Private Option Sale | 5,000 | $69.09 | $345,450.00 | (100%) 5.01K to 8 | |
| 17-May-24 4:41 PM View: | Conley Emily Director | Nuvalent, Inc. (NUVL) | 15-May-24 | Option Exercise | 5,000 | $12.31 | $61,565.20 | 62500% 8 to 5.01K | 8% |
| 15-May-24 4:54 PM View: | Shair Matthew Director | Nuvalent, Inc. (NUVL) | 13-May-24 | Private Sale (Planned) | 37,500 | $65.84 | $2,468,870.00 | (2%) 1.7M to 1.66M | |
| 08-May-24 4:51 PM View: | Shair Matthew Director | Nuvalent, Inc. (NUVL) | 06-May-24 | Private Sale (Planned) | 37,500 | $69.48 | $2,605,520.00 | (2%) 1.74M to 1.7M |
